Cite
Oral administration of repurposed drug targeting Cyp46A1 increases survival times of prion infected mice
MLA
Tahir Ali, et al. “Oral Administration of Repurposed Drug Targeting Cyp46A1 Increases Survival Times of Prion Infected Mice.” Acta Neuropathologica Communications, vol. 9, no. 1, Apr. 2021, pp. 1–14. EBSCOhost, https://doi.org/10.1186/s40478-021-01162-1.
APA
Tahir Ali, Samia Hannaoui, Satish Nemani, Waqas Tahir, Irina Zemlyankina, Pearl Cherry, Su Yeon Shim, Valerie Sim, Hermann M. Schaetzl, & Sabine Gilch. (2021). Oral administration of repurposed drug targeting Cyp46A1 increases survival times of prion infected mice. Acta Neuropathologica Communications, 9(1), 1–14. https://doi.org/10.1186/s40478-021-01162-1
Chicago
Tahir Ali, Samia Hannaoui, Satish Nemani, Waqas Tahir, Irina Zemlyankina, Pearl Cherry, Su Yeon Shim, Valerie Sim, Hermann M. Schaetzl, and Sabine Gilch. 2021. “Oral Administration of Repurposed Drug Targeting Cyp46A1 Increases Survival Times of Prion Infected Mice.” Acta Neuropathologica Communications 9 (1): 1–14. doi:10.1186/s40478-021-01162-1.